KATP channels of mouse skeletal muscle: mechanism of channel blockage by AMP-PNP.
Single ATP-sensitive potassium channels (KATP channels) were studied in inside-out membrane patches excised from mouse skeletal muscle. Channel blockage by the non-hydrolysable ATP analogue AMP-PNP was investigated in the absence or presence of 1 mM MgCl2 with K(+)-rich solutions bathing the internal membrane surface. Currents through single. KATP channels were recorded at -40 and +40 mV. AMP-PNP (5 to 500 microM; Li salt) reduced the open-probability po of KATP channels and decreased the single-channel currents at high nucleotide concentrations by approximately 10%. Half maximal reduction of po at -40 mV was observed at nucleotide concentrations of 29 microM in the absence and of 39 microM in the presence of Mg2+. The steepness of the AMP-PNP concentration-response curves was strongly affected by Mg2+, the Hill coefficients of the curves were 0.6 in the absence and 1.6 in the presence of 1 mM MgCl2. The efficacies of channel blockage by AMP-PNP at -40 and +40 mV were not significantly different. The results indicate that a KATP channel can bind more divalent Mg(2+)-complexes of AMP-PNP than trivalent protonated forms of the nucleotide and that channel blockage is hardly affected by the membrane electric field. To estimate the contribution of lithium ions to the observed results, we studied the effects of LiCl (0.8 to 10 mM) in the Mg(2+)-free solution on the single channel current i. At a Li+ concentration of 10 mM, i was hardly affected at -40 mV but reduced by a factor of 0.75 at +40 mV. The results are interpreted by a fast, voltage-dependent blockage of KATP channels by internal Li+ ions.
Hehl
S
S
I. Physiologisches Institut, Universität des Saarlandes, Homburg, Germany.
Neumcke
B
B
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000266:Adenylyl Imidodiphosphate / Q000494:pharmacology*; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D015640:Ion Channel Gating; D007700:Kinetics; D018021:Lithium Chloride / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D018482:Muscle, Skeletal / Q000502:physiology*; D011188:Potassium / Q000494:pharmacology; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000502:physiology*; D011336:Probability
D026902:Potassium Channel Blockers; D015221:Potassium Channels; D000266:Adenylyl Imidodiphosphate; D000255:Adenosine Triphosphate; D018021:Lithium Chloride; D008274:Magnesium; D011188:Potassium